Bio-Techne (TECH) Revenue — Quarter Ended Jun 30, 2025
Revenue increased compared to the prior quarter and rose relative to the same quarter last year. The sequential growth was modest, while the year-over-year gain was more pronounced.
Key takeaway
Quarter ended Jun 30, 2025 · FY2025 Q4
Revenue increased compared to the prior quarter and rose relative to the same quarter last year. The sequential growth was modest, while the year-over-year gain was more pronounced.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$317M
Revenue reported for this quarter.
Quarter-over-quarter
+0.2%
Change from the immediately preceding quarter.
Year-over-year
+3.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$1.2B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2024 | $289.5M | +4.5% |
| Dec 31, 2024 | $297M | +9.0% |
| Mar 31, 2025 | $316.2M | +4.2% |
| Jun 30, 2025 | $317M | +3.5% |
Revenue performance
The reported revenue moved higher from the immediately preceding quarter. The increase was slight, indicating a stable sequential performance.
Quarterly comparison
Compared with the same quarter one year earlier, revenue was higher. The year-over-year improvement was larger than the sequential change, reflecting stronger annual growth.
What to watch
The filing context mentions liquidity and capital resources but does not provide specific revenue drivers or risks for this quarter.